लोड हो रहा है...
Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia
BACKGROUND: Metabolic syndrome in patients with schizophrenia is a major health concern. The efficacy and safety of adjunctive rosuvastatin in treating dyslipidemia were controversial. AIMS: To assess the efficacy and safety of adjunctive rosuvastatin for dyslipidemia in patients with schizophrenia....
में बचाया:
| में प्रकाशित: | Shanghai Arch Psychiatry |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Shanghai Municipal Bureau of Publishing
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5925598/ https://ncbi.nlm.nih.gov/pubmed/29719353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11919/j.issn.1002-0829.217156 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|